<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">717304</article-id><article-id pub-id-type="doi">10.18565/pharmateca.2026.4.117-126</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Dermatology/allergology</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Дерматология/аллергология</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of human herpesvirus infections in the pathogenesis of immune-inflammatory dermatoses. Review article, part I</article-title><trans-title-group xml:lang="ru"><trans-title>Роль герпесвирусных инфекций человека в патогенезе иммуновоспалительных дерматозов. Обзорная статья, часть I</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Evdokimov</surname><given-names>Evgeny Y.</given-names></name><name xml:lang="ru"><surname>Евдокимов</surname><given-names>Евгений Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Leading Researcher, Clinical Department of Infectious Pathology, Dermatovenerologist</p></bio><bio xml:lang="ru"><p>д.м.н., ведущий науч. сотр. клинического отдела инфекционной патологии, врач-дерматовенеролог</p></bio><email>elene-elene@bk.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Svechnikova</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Свечникова</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Department of Skin and Venereal Diseases with a Course in Cosmetology, Head of the Department of Dermatovenereology and Cosmetology</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры «Кожные и венерические болезни с курсом косметологии», зав. отделением дерматовенерологии и косметологии</p></bio><email>elene-elene@bk.ru</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8262-3938</contrib-id><name-alternatives><name xml:lang="en"><surname>Domonova</surname><given-names>Elvira A.</given-names></name><name xml:lang="ru"><surname>Домонова</surname><given-names>Эльвира Алексеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Head of the Department of Dermatovenereology and Cosmetology, Laboratory of Molecular Diagnostics and Epidemiology of Opportunistic Infections, Department of Molecular Diagnostics and Epidemiology</p></bio><bio xml:lang="ru"><p>д.м.н., зав. лабораторией молекулярной диагностики и эпидемиологии оппортунистических инфекций отдела молекулярной диагностики и эпидемиологии</p></bio><email>elene-elene@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9459-8143</contrib-id><name-alternatives><name xml:lang="en"><surname>Ponezheva</surname><given-names>Liana O.</given-names></name><name xml:lang="ru"><surname>Понежева</surname><given-names>Лиана Оскаровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Allergist-Immunologist</p></bio><bio xml:lang="ru"><p>к.м.н., врач аллерголог-иммунолог</p></bio><email>elene-elene@bk.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7194-8219</contrib-id><name-alternatives><name xml:lang="en"><surname>Rzhevskaya</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Ржевская</surname><given-names>Елена Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Chief Physician</p></bio><bio xml:lang="ru"><p>к.м.н., Главный врач</p></bio><email>elene-elene@bk.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being</institution></aff><aff><institution xml:lang="ru">Центральный научно-исследовательский институт эпидемиологии Роспотребнадзора</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Polyclinic No. 1 of the Administrative Directorate of the President of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Поликлиника № 1 Управления делами Президента РФ</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Russian Biotechnology University (ROSBIOTECH)</institution></aff><aff><institution xml:lang="ru">Российский биотехнологический университет (РОСБИОТЕХ)</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">City Polyclinic No. 180, Moscow Healthcare Department</institution></aff><aff><institution xml:lang="ru">Городская поликлиника № 180 ДЗМ</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></pub-date><pub-date date-type="collection"><year>2026</year></pub-date><volume>33</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>117</fpage><lpage>126</lpage><history><date date-type="received" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-08-17"><day>17</day><month>08</month><year>2026</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, ООО «Бионика Медиа»</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://journals.eco-vector.com/2073-4034/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/717304">https://journals.eco-vector.com/2073-4034/article/view/717304</self-uri><abstract xml:lang="en"><p>Human herpes viruses, being among the oldest pathogens, pose a significant health problem. Their unique ability to affect various organs and systems, as well as persist in the body, determines the chronic nature of the infection. Viruses most often enter through damaged skin and mucous membranes, triggering a cascade of immune responses, beginning with innate immunity in the skin and extending to other parts of the immune system as the virus replicates. the differentiated Immune response in herpes simplex virus monoinfection compared to coinfections caused by multiple herpesvirus types is of particular interest.</p> <p>This review analyzes the relationship between latency and persistence of human herpes viruses and immune response characteristics in patients with inflammatory dermatoses that worsen with recurrent herpesvirus infections. Particular attention is paid to the role of herpes simplex virus types 1 and 2 in modulating immune responses and inflammatory processes. The article demonstrates that recurrences of herpesvirus infections and exacerbations of inflammatory dermatoses may be linked to common regulatory pathways of the immune response. These findings highlight the need for further research to develop new therapeutic approaches for the treatment of these interrelated pathologies.</p></abstract><trans-abstract xml:lang="ru"><p>Вирусы герпеса человека, являясь одними из древнейших патогенов, представляют собой значительную проблему для здоровья. Их уникальная способность поражать разнообразные органы и системы, а также персистировать в организме обуславливает хронический характер инфекции. Проникновение вирусов чаще всего происходит через поврежденные кожные покровы и слизистые оболочки, запуская каскад иммунных реакций, начиная с врожденного иммунитета в коже и распространяясь на другие звенья иммунной системы по мере репликации вируса. Особый интерес представляет собой дифференцированный иммунный ответ при моноинфекции вирусом простого герпеса по сравнению с коинфекциями, вызванными несколькими типами герпесвирусов.</p> <p>Настоящий обзор посвящен анализу взаимосвязи между латенцией и персистенцией вирусов герпеса человека и особенностями иммунного ответа у пациентов с воспалительными дерматозами, обостряющимися на фоне рецидивов герпесвирусных инфекций. Особое внимание уделено роли вирусов простого герпеса 1 и 2 типов в модуляции иммунных реакций и воспалительных процессов. В статье показано, что рецидивы герпесвирусных инфекций и обострения воспалительных дерматозов могут быть связаны с общими регуляторными путями иммунного ответа. Полученные данные подчеркивают необходимость дальнейших исследований для разработки новых терапевтических подходов к лечению этих взаимосвязанных патологий.</p></trans-abstract><kwd-group xml:lang="en"><kwd>human herpesviruses</kwd><kwd>inflammatory dermatoses</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирусы герпеса человека</kwd><kwd>воспалительные дерматозы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Yapijakis C. Hippocrates of Kos, the father of clinical medicine, and Asclepiades of Bithyn-ia, the father of molecular medicine. Review. InVivo. 2009 Jul-Aug;23(4):507-14.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Dotto-Maurel A., Arzul I., Morga B., Chevignon G. Herpesviruses: overview of systematics, genomic complexity and life cycle. Virol J. 2025 May 22;22(1):155. https://dx.doi.org/10.1186/s12985-025-02779-7</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Сайдуллаева И.С., Тихомиров Д.С., Дроков М.Ю., Туполева Т.А. Вирус герпеса человека 6-го типа (Orthoherpesviridae: Roseolovirus): особенности эпидемиологии и диа-гностики. Вопросы вирусологии. 2024;69(1):22-30. [Saidullaeva I.S., Tikhomirov D.S., Drokov M.Yu., Tupoleva T.A. Human herpes virus type 6 (Orthoherpesviridae: Roseolovi-rus): features of epidemiology and diagnostics. Voprosy Virusologii. 2024;69(1):22-30. (In Russ.)]. https://dx.doi.org/10.36233/0507-4088-20</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cevenini A., De Antonellis P., Mazzarelli L.L., et al. Lytic or Latent Phase in Human Cyto-megalovirus Infection: An Epigenetic Trigger. Int J Mol Sci. 2025;26(23):11554. https://doi.org/10.3390/ijms262311554</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gatherer D., Depledge D.P., Hartley C.A., et al. ICTV Virus Taxonomy Profile: Herpesviri-dae 2021. J Gen Virol. 2021 Oct;102(10):001673. https://dx.doi.org/10.1099/jgv.0.001673</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Клинические рекомендации. Простой герпес (ПГ) у взрослых. Разработчик клинической рекомендации: Национальная ассоциация специалистов по инфекционным болезням имени академика В.И. Покровского (НАСИБ); Общероссийская общественная организация «Национальный альянс дерматовенерологов и косметологов». Одобрено Научно-практическим Советом МЗ РФ 2025 г. [Clinical Guidelines. Herpes Simplex Virus (HSV) in Adults. Clinical Guideline Developer: V.I. Pokrovsky National Association of In-fectious Disease Specialists (NASIB); All-Russian Public Organization «National Alliance of Dermatovenerologists and Cosmetologists.» Approved by the Scientific and Practical Coun-cil of the Ministry of Health of the Russian Federation, 2025. (In Russ.)].</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Shah H.A., Meiwald A., Perera C., et al. Global Prevalence of Varicella-Associated Compli-cations: A Systematic Review and Meta-Analysis. Infect Dis Ther. 2024 Jan;13(1):79-103. https://dx.doi.org/10.1007/s40121-023-00899-7</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Whitley R.J. Herpesviruses. In: Baron S., editor. Medical Microbiology. 4th edition. Galves-ton (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 68. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8157/</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hoover K., Higginbotham K. Epstein-Barr Virus. [Updated 2023 Aug 8]. In: StatPearls [In-ternet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559285/</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Mamimandjiami A.I., Engone-Ondo J.-D., Moussavou-Boundzanga P., et al. Kaposi’s Sar-coma: A Non-Communicable Outcome Mainly Prompted by Communicable Diseases in Sub-Saharan Africa. Int J Mol Sci. 2025;26(20):10198. https://doi.org/10.3390/ijms262010198</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Neugebauer E., Walter S., Tan J., et al. Herpesviruses mimic zygotic genome activation to promote viral replication. Nat Commun. 2025 Jan 16;16(1):710. https://dx.doi.org/10.1038/s41467-025-55928-5 Erratum in: Nat Commun. 2025 Mar 5;16(1):2211. https://dx.doi.org/10.1038/s41467-025-57313-8</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Shahnazaryan, D., Khalil, R., Wynne C. et al. Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction. Sci Rep. 2020;10:22216. https://doi.org/10.1038/s41598-020-77725-4</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chen Y.C., Li H., Martin-Caraballo M., Hsia S.V. Establishing a Herpesvirus Quiescent In-fection in Differentiated Human Dorsal Root Ganglion Neuronal Cell Line Mediated by Mi-cro-RNA Overexpression. Pathogens. 2022 Jul 16;11(7):803. https://dx.doi.org/10.3390/pathogens11070803</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rivas T., Goodrich J.A., Kugel J.F. The Herpes Simplex Virus 1 Protein ICP4 Acts as both an Activator and a Repressor of Host Genome Transcription during Infection. Mol Cell Biol. 2021 Sep 24;41(10):e0017121. https://dx.doi.org/10.1128/MCB.00171-21</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>St Leger A.J., Koelle D.M., Kinchington P.R., Verjans G.M.G.M. Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man. Front Immunol. 2021 Sep 15;12:723809. https://dx.doi.org/10.3389/fimmu.2021.723809</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Long X., Yang Z., Li Y., et al. BRLF1-dependent viral and cellular transcriptomes and tran-scriptional regulation during EBV primary infection in B lymphoma cells. Genomics. 2021 Jul;113(4):2591-2604. https://dx.doi.org/10.1016/j.ygeno.2021.05.039</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bentz G.L., Liu R., Hahn A.M., et al. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology. 2010 Jun 20;402(1):121-8. https://dx.doi.org/10.1016/j.virol.2010.03.014</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Adamson C.S., Nevels M.M. Bright and Early: Inhibiting Human Cytomegalovirus by Tar-geting Major Immediate-Early Gene Expression or Protein Function. Viruses. 2020 Jan 16;12(1):110. https://dx.doi.org/10.3390/v12010110</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Stinski M.F., Meier J.L. Immediate–early viral gene regulation and function. In: Arvin A., Campadelli-Fiume G., Mocarski E., et al., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 17. Avail-able from: https://www.ncbi.nlm.nih.gov/books/NBK47383/</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Wen K.W., Wang L., Menke J.R., Damania B. Cancers associated with human gam-maherpesviruses. FEBS J. 2022 Dec;289(24):7631-7669. https://dx.doi.org/10.1111/febs.16206</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Murata T. Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival. Microorganisms. 2021;9(4):778. https://doi.org/10.3390/microorganisms9040778</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Le Hars M., Joussain C., Jégu T., Epstein A.L. Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an update. Gene Ther. 2025 May;32(3):173-183. doi: 10.1038/s41434-024-00500-x</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Nalwoga A., Roshan R., Moore K. et al. Kaposi’s sarcoma-associated herpesvirus T cell re-sponses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021;12:7323. https://doi.org/10.1038/s41467-021-27623-8</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Landmeier S., Altvater B., Pscherer S. et al. Activated human gammadelta T cells as stimula-tors of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer. J Immunother. 2009 Apr;32(3):310-21. https://dx.doi.org/10.1097/CJI.0b013e31819b7c30</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>DuRaine G., Wisner T.W., Johnson D.C. Characterization of the Herpes Simplex Virus (HSV) Tegument Proteins That Bind to gE/gI and US9, Which Promote Assembly of HSV and Transport into Neuronal Axons. J Virol. 2020 Nov 9;94(23):e01113-20. https://dx.doi.org/10.1128/JVI.01113-20</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Lenart M., Działo E., Kluczewska A., et al. miRNA Regulation of NK Cells Antiviral Re-sponse in Children With Severe and/or Recurrent Herpes Simplex Virus Infections. Front Immunol. 2021 Jan 25;11:589866. https://dx.doi.org/10.3389/fimmu.2020.589866</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Penner I., Krämer N., Hirsch J., et al. Deletion of the Human Cytomegalovirus US2 to US11 Gene Family Members Impairs the Type-I Interferon Response. Viruses. 2025;17(3):426. https://doi.org/10.3390/v17030426</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Mariuzza R.A., Singh P., Karade S.S., et al. Recognition of Self and Viral Ligands by NK Cell Receptors. Immunol Rev. 2025 Jan;329(1):e13435. https://dx.doi.org/10.1111/imr.13435</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Meng W., Han SC., Li CC. et al. Multifunctional viral protein γ34.5 manipulates nucleolar protein NOP53 for optimal viral replication of HSV-1. Cell Death Dis. 2018;9:103 https://doi.org/10.1038/s41419-017-0116-2</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Suraweera C.D., Hinds M.G., Kvansakul M. Structural Insight into KsBcl-2 Mediated Apop-tosis Inhibition by Kaposi Sarcoma Associated Herpes Virus. Viruses. 2022;14(4):738. https://doi.org/10.3390/v14040738</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Yujie Ren et al. Human cytomegalovirus UL36 inhibits IRF3-dependent immune signaling to counterbalance its immunoenhancement as apoptotic inhibitor. Sci. Adv. 2023;9:eadi6586. https://dx.doi.org/10.1126/sciadv.adi6586</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Broussard G., Damania B. KSHV: Immune Modulation and Immunotherapy. Front Immu-nol. 2020 Feb 7;10:3084. doi: 10.3389/fimmu.2019.03084</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Oliver S.L. The Structures and Functions of VZV Glycoproteins. Curr Top MicrobiolIm-munol. 2023;438:25-58. https://dx.doi.org/10.1007/82_2021_243</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Ning Y., Huang Y., Wang M., et al. Alphaherpesvirus glycoprotein E: A review of its inter-actions with other proteins of the virus and its application in vaccinology. Front Microbiol. 2022 Aug 4;13:970545. https://dx.doi.org/10.3389/fmicb.2022.970545</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>BahojbMahdavi S.Z., Jebelli A., Aghbash P.S., et al. A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection. Med Res Rev. 2025 Mar;45(2):349-425. https://dx.doi.org/10.1002/med.22073</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Labetoulle M., Boutolleau D., Burrel S., et al. Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: Facts for the clinician. Ocul Surf. 2023 Apr;28:336-350. https://dx.doi.org/10.1016/j.jtos.2021.07.002</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Nie J., Zhou L., Tian W. et al. Deep insight into cytokine storm: from pathogenesis to treat-ment. Sig Transduct Target Ther. 2025;10:112. https://doi.org/10.1038/s41392-025-02178-y</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Sutter J., Hope J.L., Wigdahl B., Miller V., Krebs F.C. Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach. Viruses. 2025;17(5):600. https://doi.org/10.3390/v17050600</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Атажахова М.Г., Чудилова Г.А., Ломтатидзе Л.В., Поезжаев Е.А. Вариативность изменений про- и противовоспалительных цитокинов на фоне дефицита IFNα и IFNγ у пациентов с постковидным синдромом, ассоциированным с активацией хронических герпесвирусных инфекций. Инфекция и иммунитет. 2024;14(3):488-494. [Atazhakhova M.G., Chudilova G.A., Lomtatidze L.V., Poezzhaev E.A. Variability of changes in pro- and anti-inflammatory cytokines against the background of IFNα and IFNγ deficiency in patients with post-COVID syndrome associated with activation of chronic herpesvirus infections. In-fektsiya i immunitet. 2024;14(3):488–494. (In Russ.)]. https://dx.doi.org/10.15789/2220-7619-VOC-16749</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Соломай Т.В., Семененко Т.А., Каражас Н.В. др. Особенности изменения показателей иммунного статуса лиц с активным и латентным формами герпесвирусных инфекций. Пермский медицинский журнал (сетевое издание Perm Medical Journal). 2021;38(1):46-63. [Solomai T.V., Semenenko T.A., Karazhas N.V., et al. Features of changes in immune status indicators of individuals with active and latent forms of herpesvirus infec-tions. Perm Medical Journal (online publication Perm Medical Journal). 2021;38(1):46-63. (In Russ.)]. https://dx.doi.org/10.17816/pmj38146-63</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Wang H., Zhang N., Xu R., et al. The PD-1/PD-L1 pathway and Epstein-Barr virus. Eur J Med Res. 2025 Jun 18;30(1):486. https://dx.doi.org/10.1186/s40001-025-02694-1</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Соломай Т.В., Семененко Т.А., Ведунова С.Л. и др. Роль активной герпесвирусной инфекции в формировании атопического дерматита и псориаза. Сибирский научный медицинский журнал. 2022;42(3):94-102. [Solomai T.V., Semenenko T.A., Vedunova S.L., et al. The role of active herpesvirus infection in the development of atopic dermatitis and psoriasis. Siberian Scientific Medical Journal. 2022;42(3):94-102. (In Russ.)].</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Ricchi F., Caramaschi S, Sala A., et al. Candida albicans as a Trailblazer for Herpes Simplex Virus-2 Infection Against an In Vitro Reconstituted Human Vaginal Epithelium. Microor-ganisms. 2025;13(4):905. https://doi.org/10.3390/microorganisms13040905</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Espinoza Urzua I., Vidal Vidal M.I., Vega Solano M., et al. Skin Barrier Dysfunction in Chronic Dermatoses: From Pathophysiology to Emerging Therapeutic Strategies. Cureus. 2025 Jun 28;17(6):e86937. https://dx.doi.org/10.7759/cureus.86937</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Su D., Han L., Shi C., et al. An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application. Virulence. 2024 Dec;15(1):2425744. https://dx.doi.org/10.1080/21505594.2024.2425744</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Glasebach H., Denzinger L., Rupp S., Burger-Kentischer A. Human epidermis models demonstrate mediator role of TLR2 and TLR3 for psoriatic inflammation. Front Med (Lau-sanne). 2025 Sep 9;12:1663279. https://dx.doi.org/10.3389/fmed.2025.1663279</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Tamagawa-Mineoka R. Toll-like receptors: their roles in pathomechanisms of atopic dermati-tis. Front Immunol. 2023 Sep 5;14:1239244. https://dx.doi.org/10.3389/fimmu.2023.1239244</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Huang C., Li W., Ren X., et al. The Crucial Roles and Research Advances of cGAS-STING Pathway in Cutaneous Disorders. Inflammation. 2023 Aug;46(4):1161-1176. https://dx.doi.org/10.1007/s10753-023-01812-7</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Xu T., Zhong X., Luo N., et al. Review of Excessive Cytosolic DNA and Its Role in AIM2 and cGAS-STING Mediated Psoriasis Development. Clin Cosmet Investig Dermatol. 2024 Oct 22;17:2345-2357. https://dx.doi.org/10.2147/CCID.S476785</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Cai M., Liao Z., Zou X., et al. Herpes Simplex Virus 1 UL2 Inhibits the TNF-α-Mediated NF-κB Activity by Interacting With p65/p50. Front Immunol. 2020 May 13;11:549. https://dx.doi.org/10.3389/fimmu.2020.00549</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Liu A.R., Sarkar N., Cress J.D., et al. NF-κB c-Rel is a critical regulator of TLR7-induced in-flammation in psoriasis. EBioMedicine. 2024 Dec;110:105452. https://dx.doi.org/10.1016/j.ebiom.2024.105452</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Li D., Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021 Aug 4;6(1):291. doi: 10.1038/s41392-021-00687-0</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Liu Y., Chen L., Liu W., et al. Cepharanthine Suppresses Herpes Simplex Virus Type 1 Rep-lication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways. Front Microbiol. 2021 Dec 9;12:795756. https://dx.doi.org/10.3389/fmicb.2021.795756</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Guo J., Zhang H., Lin W. et al. Signaling pathways and targeted therapies for psoriasis. Sig Transduct Target Ther. 2023;8:437. https://doi.org/10.1038/s41392-023-01655-6.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Hu X., Zeng Q., Xiao J., et al. Herpes Simplex Virus 1 Induces Microglia Gasdermin D-Dependent Pyroptosis Through Activating the NLR Family Pyrin Domain Containing 3 In-flammasome. Front Microbiol. 2022 Mar 21;13:838808. https://dx.doi.org/10.3389/fmicb.2022.838808</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Li L., Liu J., Lu J., et al. Interventions in cytokine signaling: novel horizons for psoriasis treatment. Front Immunol. 2025 Apr 15;16:1573905. https://dx.doi.org/10.3389/fimmu.2025.1573905</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Scheib N., Tiemann J., Becker C., et al. The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity. Front Immunol. 2022 Jun 28;13:929000. https://dx.doi.org/10.3389/fimmu.2022.929000</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Behr N.J., Pierre S., Ickelsheimer T. et al. High content imaging shows distinct macrophage and dendritic cell phenotypes for psoriasis and atopic dermatitis. Sci Rep. 2025;15:18904. https://doi.org/10.1038/s41598-025-99727-w</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Wang L., Liu R., Tang Y., et al. Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies. Int J Mol Sci. 2025;26(18):9233. https://doi.org/10.3390/ijms26189233</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Калантар Неестанаки М., Мехдипур А. Взаимодействия между вирусными и бактериальными патогенами в развитии инфекций: обзор с акцентом на вирус простого герпеса. Инфекция и иммунитет. 2025;15(3):465-475. [Kalantar Neestanaki M., Mehdipour A. Interactions between viral and bacterial pathogens in the development of infections: a re-view with emphasis on herpes simplex virus. Infektsiya i immunitet. 2025;15(3):465–475. (In Russ.)]. https://dx.doi.org/10.15789/2220-7619-TIB-17749</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Dias de Oliveira N.F., Santi C.G., Maruta C.W., Aoki V. Plasmacytoid dendritic cells in dermatology. An Bras Dermatol. 2021 Jan-Feb;96(1):76-81. https://dx.doi.org/10.1016/j.abd.2020.08.006</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Ngo C., Garrec C., Tomasello E. et al. The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond. Cell Mol Immunol. 2024;21:1008–1035. https://doi.org/10.1038/s41423-024-01167-5</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Zhang J., Xu X., Duan S., et al. Characterization of the Immunologic Phenotype of Dendritic Cells Infected With Herpes Simplex Virus 1. Front Immunol. 2022 Jul 5;13:931740. https://dx.doi.org/10.3389/fimmu.2022.931740</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Domínguez-Díaz C., Varela-Trinidad G.U., Muñoz-Sánchez G., et al. To Trap a Pathogen: Neutrophil Extracellular Traps and Their Role in Mucosal Epithelial and Skin Diseases. Cells. 2021 Jun 11;10(6):1469. https://dx.doi.org/10.3390/cells10061469</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Afonina I.S., Van Nuffel E., Beyaert R. Immune responses and therapeutic options in psoria-sis. Cell Mol Life Sci. 2021 Mar;78(6):2709-2727. https://dx.doi.org/10.1007/s00018-020-03726-1</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Ouyang K., Oparaugo N., Nelson A.M., Agak G.W. T Cell Extracellular Traps: Tipping the Balance Between Skin Health and Disease. Front Immunol. 2022 Jun 20;13:900634. https://dx.doi.org/10.3389/fimmu.2022.900634</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Сорокина Е.В., Бишева И.В. Роль клеток врожденной иммунной системы при псориазе. Вестник дерматологии и венерологии. 2022;98(5):59-64. [Sorokina E.V., Bisheva I.V. The role of innate immune system cells in psoriasis. Vestnik dermatologii i venerologii. 2022;98(5):59-64. (In Russ.)]. https://dx.doi.org/10.25208/vdv1330</mixed-citation></ref></ref-list></back></article>
